ASK REDCHAT ANYTHING ABOUT ORAGENICS INC.
Oragenics Inc. (NYSE AMERICAN: OGEN)
Listen to this Section
$0.61
-0.0030
(
-0.49% )
16.3K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ONP-002DetailsTraumatic brain injury |
Phase 2a |
Market Data
| Open |
$0.61 |
| Previous Close |
$0.61 |
| Volume |
16.3K |
| Market Cap |
$2.75M |
| Day Range |
$0.58 - $0.61 |
| 52 Week Range |
$0.50 - $5.24 |
| Shares Outstanding |
4.51M |
| Change % |
-0.49% |
| Net Change |
▼ -0.0030 |
| Insider Ownership |
-0.06% |
| Exchange |
NYSE AMERICAN |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2003 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-228,704.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-01-02 |
Sale |
-75000.00 |
REDMOND J MICHAEL |
| 2023-12-01 |
Sale |
-3500.00 |
Telling Fred |
| 2023-10-06 |
Sale |
-5102.00 |
GANDOLFO JOHN P |
| 2023-10-06 |
Sale |
-5102.00 |
Cassidy Bruce A. Sr. |
| 2023-08-10 |
Sale |
-25000.00 |
Telling Fred |
| 2023-08-10 |
Sale |
-25000.00 |
POPE CHARLES L |
| 2023-08-10 |
Sale |
-25000.00 |
Murphy Kimberly M |
| 2023-08-10 |
Sale |
-25000.00 |
KOSKI ROBERT C |
| 2023-08-10 |
Sale |
-15000.00 |
Huffman Janet |
| 2023-08-10 |
Sale |
-25000.00 |
DUNTON ALAN W |